Graph | Cluster | Transcripts | Mean logCPM | logFC M26/M2 | FDR M26/M2 | Classification | Human genes | C.elegans genes | Annotation |
---|---|---|---|---|---|---|---|---|---|
|
MligTC455_50376 | Mlig455_021483 | 5.12 | 0.656 | 0.000 | GenAge HSPG2 |
heparan sulfate proteoglycan 2 | unc-52 | Mlig455_021483 {REF} {Length: 7204} {Pfam: Immunoglobulin domain [PF13927.8, score=105.9]; Immunoglobulin I-set domain [PF07679.18, score=70.3]; Immunoglobulin V-set domain [PF07686.19, score=68.2]; Immunoglobulin domain [PF00047.27, score=60.3]; Immunoglobulin domain [PF13895.8, score=58.0]; Laminin B (Domain IV) [PF00052.20, score=53.8]; Low-density lipoprotein receptor domain class A [PF00057.20, score=29.9]; Laminin EGF domain [PF00053.26, score=22.8]} {Human: ENSG00000142798, HSPG2, heparan sulfate proteoglycan 2, [Score=122, Expect=4e-27]} {Mouse: ENSMUSG00000028763, Hspg2, perlecan (heparan sulfate proteoglycan 2), [Score=111, Expect=7e-24]} {Dmel: FBgn0284408, trol, terribly reduced optic lobes, [Score=109, Expect=2e-23]} {Celegans: WBGene00006787, unc-52, Basement membrane proteoglycan, [Score=157, Expect=6e-38]} {Smed: dd_Smed_v6_6915_0_1, dd_Smed_v6_6915_0_1, [Score=154, Expect=3e-37]} {RNA1509_3385} {RNA1310_393.1} {RNA815_120.1} {SMEDTYPE: Muscle [dd_Smed_v6_6915_0_1, heparan sulfate proteoglycan 2 (HSPG2)]} {SMEDTYPE: X2 [raj_facs_types]} {SMEDTYPE: Sexual_biased [CUFF.205231.0]} |